NMRA-335140 80 mg
NMRA-335140-202
Phase 2 small_molecule completed
Quick answer
NMRA-335140 80 mg for Major Depressive Episode Associated With Bipolar II Disorder is a Phase 2 program (small_molecule) at Neumora Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Neumora Therapeutics
- Indication
- Major Depressive Episode Associated With Bipolar II Disorder
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed